Trial
NCT05773326
Superselective Intra-arterial Cerebral Infusion of Temsirolimus in HGG
Early Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Nader Sanai
Collaborators
Barrow Neurological Institute; Ivy Brain Tumor Center
Condition
High Grade Glioma
Intervention
Temsirolimus
Why stopped
Study terminated due to unavailability of the investigational product required to continue the study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-14